Skip to main content
Top
Published in: BMC Infectious Diseases 1/2011

Open Access 01-12-2011 | Research article

A prospective study of vaginal trichomoniasis and HIV-1 shedding in women on antiretroviral therapy

Authors: Linnet N Masese, Susan M Graham, Ruth Gitau, Nobert Peshu, Walter Jaoko, Jeckoniah O Ndinya-Achola, Kishorchandra Mandaliya, Barbra A Richardson, Julie Overbaugh, R Scott McClelland

Published in: BMC Infectious Diseases | Issue 1/2011

Login to get access

Abstract

Background

Trichomonas vaginalis has been associated with increased vaginal HIV-1 RNA shedding in antiretroviral therapy (ART)-naïve women. The effect of trichomoniasis on vaginal HIV-1 shedding in ART-treated women has not been characterized. We tested the hypothesis that T. vaginalis infection would increase vaginal HIV-1 RNA shedding in women on ART, and that successful treatment would reduce vaginal HIV-1 RNA levels.

Methods

We conducted a prospective cohort study including monthly follow-up of 147 women receiving ART in Mombasa, Kenya. Those with T. vaginalis infection, defined by the presence of motile trichomonads on vaginal saline wet mount, received treatment with single dose metronidazole (2 g). Test of cure was performed at the next monthly visit. Using the pre-infection visit as the reference category, we compared detection of vaginal HIV-1 RNA before versus during and after infection using generalized estimating equations. A cut-off of 100 HIV-1 RNA copies/swab was used as the lower limit for linear quantitation.

Results

Among 31 women treated for trichomoniasis, the concentration of vaginal HIV-1 RNA was above the limit for quantitation before, during, and after T. vaginalis infection in 4 (13% [95% CI 4% - 30%]), 4 (13% [95% CI 4% - 30%]), and 5 (16% [95% confidence interval {CI} 5% - 34%]) women respectively. After adjusting for potential confounding factors, we could detect no difference in the likelihood of detecting vaginal HIV-1 RNA before versus during infection (odds ratio [OR] 1.41, 95% CI 0.23 - 8.79, p = 0.7). In addition, detection of HIV-1 RNA was similar before infection versus after successful treatment (OR 0.68, 95% CI (0.13 - 3.45), p = 0.6).

Conclusion

Detection of vaginal HIV-1 RNA during ART was uncommon at visits before, during and after T. vaginalis infection.
Literature
2.
go back to reference Baeten JM, Overbaugh J: Measuring the infectiousness of persons with HIV-1: opportunities for preventing sexual HIV-1 transmission. Curr HIV Res. 2003, 1: 69-86. 10.2174/1570162033352110.CrossRefPubMed Baeten JM, Overbaugh J: Measuring the infectiousness of persons with HIV-1: opportunities for preventing sexual HIV-1 transmission. Curr HIV Res. 2003, 1: 69-86. 10.2174/1570162033352110.CrossRefPubMed
3.
go back to reference Coombs RW, Reichelderfer PS, Landay AL: Recent observations on HIV type-1 infection in the genital tract of men and women. Aids. 2003, 17: 455-480. 10.1097/00002030-200303070-00001.CrossRefPubMed Coombs RW, Reichelderfer PS, Landay AL: Recent observations on HIV type-1 infection in the genital tract of men and women. Aids. 2003, 17: 455-480. 10.1097/00002030-200303070-00001.CrossRefPubMed
4.
go back to reference Graham SM, Holte SE, Peshu NM, Richardson BA, Panteleeff DD, Jaoko WG, Ndinya-Achola JO, Mandaliya KN, Overbaugh JM, McClelland RS: Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding. Aids. 2007, 21: 501-507. 10.1097/QAD.0b013e32801424bd.CrossRefPubMed Graham SM, Holte SE, Peshu NM, Richardson BA, Panteleeff DD, Jaoko WG, Ndinya-Achola JO, Mandaliya KN, Overbaugh JM, McClelland RS: Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding. Aids. 2007, 21: 501-507. 10.1097/QAD.0b013e32801424bd.CrossRefPubMed
5.
go back to reference Neely MN, Benning L, Xu J, Strickler HD, Greenblatt RM, Minkoff H, Young M, Bremer J, Levine AM, Kovacs A: Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2007, 44: 38-42. 10.1097/01.qai.0000248352.18007.1f.CrossRefPubMedPubMedCentral Neely MN, Benning L, Xu J, Strickler HD, Greenblatt RM, Minkoff H, Young M, Bremer J, Levine AM, Kovacs A: Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2007, 44: 38-42. 10.1097/01.qai.0000248352.18007.1f.CrossRefPubMedPubMedCentral
6.
go back to reference Hobbs MM, Kazembe P, Reed AW, Miller WC, Nkata E, Zimba D, Daly CC, Chakraborty H, Cohen MS, Hoffman I: Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex Transm Dis. 1999, 26: 381-387. 10.1097/00007435-199908000-00003.CrossRefPubMed Hobbs MM, Kazembe P, Reed AW, Miller WC, Nkata E, Zimba D, Daly CC, Chakraborty H, Cohen MS, Hoffman I: Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex Transm Dis. 1999, 26: 381-387. 10.1097/00007435-199908000-00003.CrossRefPubMed
7.
go back to reference Wang CC, McClelland RS, Reilly M, Overbaugh J, Emery SR, Mandaliya K, Chohan B, Ndinya-Achola J, Bwayo J, Kreiss JK: The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J Infect Dis. 2001, 183: 1017-1022. 10.1086/319287.CrossRefPubMed Wang CC, McClelland RS, Reilly M, Overbaugh J, Emery SR, Mandaliya K, Chohan B, Ndinya-Achola J, Bwayo J, Kreiss JK: The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J Infect Dis. 2001, 183: 1017-1022. 10.1086/319287.CrossRefPubMed
8.
go back to reference Price MA, Zimba D, Hoffman IF, Kaydos-Daniels SC, Miller WC, Martinson F, Chilongozi D, Kip E, Msowoya E, Hobbs MM, et al: Addition of treatment for trichomoniasis to syndromic management of urethritis in Malawi: a randomized clinical trial. Sex Transm Dis. 2003, 30: 516-522. 10.1097/00007435-200306000-00009.CrossRefPubMed Price MA, Zimba D, Hoffman IF, Kaydos-Daniels SC, Miller WC, Martinson F, Chilongozi D, Kip E, Msowoya E, Hobbs MM, et al: Addition of treatment for trichomoniasis to syndromic management of urethritis in Malawi: a randomized clinical trial. Sex Transm Dis. 2003, 30: 516-522. 10.1097/00007435-200306000-00009.CrossRefPubMed
9.
go back to reference Sadiq ST, Taylor S, Kaye S, Bennett J, Johnstone R, Byrne P, Copas AJ, Drake SM, Pillay D, Weller I: The effects of antiretroviral therapy on HIV-1 RNA loads in seminal plasma in HIV-positive patients with and without urethritis. Aids. 2002, 16: 219-225. 10.1097/00002030-200201250-00011.CrossRefPubMed Sadiq ST, Taylor S, Kaye S, Bennett J, Johnstone R, Byrne P, Copas AJ, Drake SM, Pillay D, Weller I: The effects of antiretroviral therapy on HIV-1 RNA loads in seminal plasma in HIV-positive patients with and without urethritis. Aids. 2002, 16: 219-225. 10.1097/00002030-200201250-00011.CrossRefPubMed
10.
go back to reference Baeten JM, Kahle E, Lingappa JR, Coombs RW, Delany-Moretlwe S, Nakku-Joloba E, Mugo NR, Wald A, Corey L, Donnell D, et al: Genital HIV-1 RNA Predicts Risk of Heterosexual HIV-1 Transmission. Sci Transl Med. 3: 77ra29- Baeten JM, Kahle E, Lingappa JR, Coombs RW, Delany-Moretlwe S, Nakku-Joloba E, Mugo NR, Wald A, Corey L, Donnell D, et al: Genital HIV-1 RNA Predicts Risk of Heterosexual HIV-1 Transmission. Sci Transl Med. 3: 77ra29-
11.
go back to reference Martin HL, Nyange PM, Richardson BA, Lavreys L, Mandaliya K, Jackson DJ, Ndinya-Achola JO, Kreiss J: Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. J Infect Dis. 1998, 178: 1053-1059. 10.1086/515654.CrossRefPubMed Martin HL, Nyange PM, Richardson BA, Lavreys L, Mandaliya K, Jackson DJ, Ndinya-Achola JO, Kreiss J: Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. J Infect Dis. 1998, 178: 1053-1059. 10.1086/515654.CrossRefPubMed
14.
go back to reference Panteleeff D, Emery S, Richardson BA, Rousseau C, Benki S, Bodrug S, Kreiss JK, Overbaugh J: Validation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay with genital swabs and breast milk samples. J Clin Microbiol. 2002, 40: 3929-3937. 10.1128/JCM.40.11.3929-3937.2002.CrossRef Panteleeff D, Emery S, Richardson BA, Rousseau C, Benki S, Bodrug S, Kreiss JK, Overbaugh J: Validation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay with genital swabs and breast milk samples. J Clin Microbiol. 2002, 40: 3929-3937. 10.1128/JCM.40.11.3929-3937.2002.CrossRef
15.
go back to reference Nugent RP, Krohn MA, Hillier SL: Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991, 29: 297-301.PubMedPubMedCentral Nugent RP, Krohn MA, Hillier SL: Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991, 29: 297-301.PubMedPubMedCentral
16.
go back to reference Ghys PD, Fransen K, Diallo MO, Ettiegne-Traore V, Coulibaly IM, Yeboue KM, Kalish ML, Maurice C, Whitaker JP, Greenberg AE, Laga M: The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d'Ivoire. Aids. 1997, 11: F85-93. 10.1097/00002030-199712000-00001.CrossRefPubMed Ghys PD, Fransen K, Diallo MO, Ettiegne-Traore V, Coulibaly IM, Yeboue KM, Kalish ML, Maurice C, Whitaker JP, Greenberg AE, Laga M: The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d'Ivoire. Aids. 1997, 11: F85-93. 10.1097/00002030-199712000-00001.CrossRefPubMed
17.
go back to reference Tanton C, Weiss HA, Le Goff J, Changalucha J, Rusizoka M, Baisley K, Everett D, Ross DA, Belec L, Hayes RJ, Watson-Jones D: Correlates of HIV-1 Genital Shedding in Tanzanian Women. PLoS One. 6: e17480- Tanton C, Weiss HA, Le Goff J, Changalucha J, Rusizoka M, Baisley K, Everett D, Ross DA, Belec L, Hayes RJ, Watson-Jones D: Correlates of HIV-1 Genital Shedding in Tanzanian Women. PLoS One. 6: e17480-
18.
go back to reference Cohen MS, Gay C, Kashuba AD, Blower S, Paxton L: Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1. Ann Intern Med. 2007, 146: 591-601.CrossRefPubMed Cohen MS, Gay C, Kashuba AD, Blower S, Paxton L: Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1. Ann Intern Med. 2007, 146: 591-601.CrossRefPubMed
19.
go back to reference McClelland RS, Wang CC, Mandaliya K, Overbaugh J, Reiner MT, Panteleeff DD, Lavreys L, Ndinya-Achola J, Bwayo JJ, Kreiss JK: Treatment of cervicitis is associated with decreased cervical shedding of HIV-1. Aids. 2001, 15: 105-110. 10.1097/00002030-200101050-00015.CrossRefPubMed McClelland RS, Wang CC, Mandaliya K, Overbaugh J, Reiner MT, Panteleeff DD, Lavreys L, Ndinya-Achola J, Bwayo JJ, Kreiss JK: Treatment of cervicitis is associated with decreased cervical shedding of HIV-1. Aids. 2001, 15: 105-110. 10.1097/00002030-200101050-00015.CrossRefPubMed
20.
go back to reference Kissinger P, Amedee A, Clark RA, Dumestre J, Theall KP, Myers L, Hagensee ME, Farley TA, Martin DH: Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis. 2009, 36: 11-16. 10.1097/OLQ.0b013e318186decf.CrossRefPubMedPubMedCentral Kissinger P, Amedee A, Clark RA, Dumestre J, Theall KP, Myers L, Hagensee ME, Farley TA, Martin DH: Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding. Sex Transm Dis. 2009, 36: 11-16. 10.1097/OLQ.0b013e318186decf.CrossRefPubMedPubMedCentral
21.
go back to reference Gitau RW, Graham SM, Masese LN, Overbaugh J, Chohan V, Peshu N, Richardson BA, Jaoko W, Ndinya-Achola JO, McClelland RS: Effect of acquisition and treatment of cervical infections on HIV-1 shedding in women on antiretroviral therapy. Aids. 24: 2733-2737. Gitau RW, Graham SM, Masese LN, Overbaugh J, Chohan V, Peshu N, Richardson BA, Jaoko W, Ndinya-Achola JO, McClelland RS: Effect of acquisition and treatment of cervical infections on HIV-1 shedding in women on antiretroviral therapy. Aids. 24: 2733-2737.
22.
go back to reference Graham SM, Masese L, Gitau R, Richardson BA, Mandaliya K, Peshu N, Jaoko W, Ndinya-Achola J, Overbaugh J, McClelland RS: Genital ulceration does not increase HIV-1 shedding in cervical or vaginal secretions of women taking antiretroviral therapy. Sex Transm Infect. 87: 114-117. Graham SM, Masese L, Gitau R, Richardson BA, Mandaliya K, Peshu N, Jaoko W, Ndinya-Achola J, Overbaugh J, McClelland RS: Genital ulceration does not increase HIV-1 shedding in cervical or vaginal secretions of women taking antiretroviral therapy. Sex Transm Infect. 87: 114-117.
Metadata
Title
A prospective study of vaginal trichomoniasis and HIV-1 shedding in women on antiretroviral therapy
Authors
Linnet N Masese
Susan M Graham
Ruth Gitau
Nobert Peshu
Walter Jaoko
Jeckoniah O Ndinya-Achola
Kishorchandra Mandaliya
Barbra A Richardson
Julie Overbaugh
R Scott McClelland
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2011
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-11-307

Other articles of this Issue 1/2011

BMC Infectious Diseases 1/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.